Fingerprint
Dive into the research topics of 'Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-Year follow-up from a randomized phase 3 trial (DASISION)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically